Abstract
Using molecular modelling studies, an active anti-HIV ethidium–arginine conjugate targeted against the viral TAR RNA sequence has been linked to an artificial ribonuclease, with the aim to obtain an irreversible inhibitor. The ribonuclease moiety consists of an N-[ N-(3-aminopropyl)-3-aminopropyl] glycine and has been constructed via two successive N-alkylations following the Fukuyama procedure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have